On-line haemodiafiltration. Safety and efficacy in long-term clinical practice

Nephrology Dialysis Transplantation

Volumn 15, Issue SUPPL. 1, 2000, Pages 60-67

  Canaud, B ^a,b   Bosc, J Y ^a   Leray Moragues, H ^a   Stec, F ^b   Argiles, A ^b   Leblanc, M ^c   Mion, C ^b  

^a Nephrology Department and AIDER   (France)

^b LAPEYRONIE HOSPITAL   (France)

^c HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIALYSIS FLUID;

CONFERENCE PAPER; DIALYSATE; FEMALE; HEMODIALYSIS; HEMOFILTRATION; HUMAN; KIDNEY FAILURE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; ONLINE SYSTEM; PRIORITY JOURNAL; SAFETY;

EID: 0034003943     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027966     Document Type: Conference Paper

References (60)

1. Canaud B, Kerr P, Argilés A, Flavier JL, Stec F, Mion C. Is hemodiafiltration the dialysis modality of choice for the next decade? Kidney Int 1993; 43 (Suppl. 41): S296-S299
2. Golper TA. What technological advances will significantly alter the future care of dialysis patients? Semin Dial 1994; 7: 323-324
3. Sprenger KBG. Haemodiafiltration. Life Support System 1983; 1: 127-136
4. Waniewski J, Lucjaanek P, Werynski A. Alternative descriptions of combined diffusive and convective mass transport in hemodialyzer. Artif Organs 1993; 17: 3-7
5. Jaffrin MY. Convective mass transfer in hemodialysis. Artif Organs 1995; 19: 1162-1171
6. Quellhorst EA, Schuenemann B, Mietzsch G. Long-term hemofiltration in 'poor risk' patients. Trans Am Soc Artif Intern Organs 1987; 33: 758-764
7. Wizemann V, Kramer W, Knopp G, Mueller K, Schütterle G. Ultrashort hemodiafiltration: efficiency and hemodynamic tolerance. Clin Nephrol 1983; 19: 24-30
8. Baldamus CA, Ernst W, Frei U, Koch KM. Sympathetic and hemodynamic response to volume removal during different forms of renal replacement therapy. Nephron 1982; 31: 324-332
9. Schmidt M, Baldamus CA, Schoeppe W. Backfiltration in hemodialyzers with highly permeable membranes. Blood Purif 1984; 2: 108-114
10. Klinkmann H, Ebbighausen H, Uhlenbusch I. High-flux dialysis, dialysale quality and backtransport. Contrib Nephrol 1993; 103: 89-97
11. Ofsthun NJ, Leypoldt JK. Ultrafiltration and backfiltration during hemodialysis. Artif Organs 1995; 19: 1143-1161
12. Henderson LW, Sanfelippo ML, Beans E. 'On-line' preparation of sterile pyrogen-free electrolyte solution. Trans ASAIO 1978; 24: 465-467
13. Ramperez P, Beau MC, Deschodt G, Flavier JL, Nielsson L, Mion C. Economic preparation of sterile pyrogen-free infusate for hemofiltration. Proc Eur Dial Transplant Assoc 1981; 18: 293-296
14. Shinzato T, Fujisawa K, Nakai S, Miwa M, Kobayakawa H, Takai I, Morita H, Maeda K. Newly developed economical and efficient push/pull hemodiafiltration. Contrib Nephrol 1994; 108: 79-86
15. Canaud B, Imbert E, Kaaki M, Assounga A, Nguyen QV, Stec F, Garred LJ, Boström M, Mion C. Clinical and microbiological evaluation of a postdilutional hemofiltration system with in-line production of substitution fluid. Blood Purif 1990; 8: 160-170
16. Shinzato T, Sezaki R, Usuda M, Maeda K, Ohbayashi S, Toyota T. Infusion-free hemodiafiltration: simultaneous hemofiltration and dialysis with no need for infusion fluid. Artif Organs 1982; 6: 453-456
17. Gonella M, Calabrese G, Pratesi G, Baldin C, Mazzotta A, Vagelli G. New reinfusate composition in high UF haemodiafiltration: electrolyte solution combined with bicarbonate. Nephrol Dial Transplant 1993; 8: 54-59
18. Canaud B, Nguyen QV, Lagarde C, Stec F, Polaschegg HD, Mion C. Clinical evaluation of a multipurpose dialysis system adequate for hemodialysis or for post-dilutional hemofiltration/ hemodiafiltration with on-line preparation of substitution fluid from dialysate. Contrib Nephrol 1985; 46: 184-186
19. Henderson LW, Besarab A, Michaels A, Bluemle LW. Blood purification by ultrafiltration and fluid replacement (diafiltration). Trans ASAIO 1967; 13: 216-222
20. Leber HW, Wizemann V, Goubeaud G, Rawer P, Schütterle G. Hemodiafiltration: a new alternative to hemofiltration and conventional hemodialysis. Artif Organs 1978; 2: 150-153
21. Canaud B, Nguyen QV, Argilés A, Polito C, Polaschegg HD, Mion C. Hemodiafiltration using dialysate as substitution fluid. Artif Organs 1987; 11: 188-190
22. Canaud B, Leray-Moragues H, Garred LJ, Turc-Baron C, Mion C. What is the role of permanent central vein access in hemodialysis patients? Semin Dial 1996; 9: 397-400
23. Canaud B, Nguyen QV, Polito C, Stec F, Mion C. Hemodiafiltration with on-line production of bicarbonate infusate. Contrib Nephrol 1989; 74: 91-100
24. Canaud B, Flavier JL, Argilés A, Stec F, Nguyen QV, Bouloux C, Garred LJ, Mion C. Hemodiafiltration with on-line production of substitution fluid: long-term safety and quantitative assessment of efficacy. Contrib Nephrol 1994; 108: 12-22
25. Canaud B, Nguyen QV, Garred LJ, Nicolle R, Mion C. Reuse of 'highly permeable' dialyzers with peroxyacetic acid as sole cleansing and disinfecting agent. ASAIO Trans 1991; 37: 653-657
26. Kerr PG, Argiles A, Canaud B, Flavier JL, Mion C. The effects of reprocessing high-flux polysulfone dialyzers with peroxyacetic B. Canaud et al. acid on beta 2-microglobulin removal in hemodiafiltration. Am J Kidney Dis 1992; 9: 433-438
27. Farrel PC. Kinetic modeling: applications in renal and related diseases. Kidney Int 1983; 24: 487-495
28. Garred LJ, Barichello DL, Canaud B, McCready W. Simple equations for protein catabolic rate determinations from pre dialysis and post dialysis blood urea nitrogen. ASAIO J 1995; 41: 889-895
29. Canaud B, Peyronnet P, Armynot AM, et al. Ultrapure water: a need for future dialysis. Nephrol Dial Transplant 1986; 1: 110
30. Baz M, Durand C, Ragon A, et al. Using ultrapure water in hemodialysis delays carpal tunnel syndrome. Int J Artif Organs 1991; 14: 681-685
31. Canaud BJM, Mion CM. Water treatment for contemporary hemodialysis; In: Jacobs C. Kjellstrand CM, Koch KM, Winchester JF, eds. Replacement of renal function by dialysis. Kluwer Academic Publishers, Dordrecht, 1996; 231-255
32. Mion CM, Canaud B. Should hemodialysis fluid be sterile? Semin Dial 1993; 6: 28-30
33. Harding GB, Pass T, Million C, Wright R, De Jarnette J, Klein E. Bacterial contamination of hemodialysis center water and dialysate: are current assay adequate? Artif Organs 1989; 13: 155-159
34. Ward RA, Luehmann DA, Klein E. Are current standards for the microbiological purity of hemodialysate adequate? Semin Dial 1989; 2: 69-72
35. Pass T, Wright R, Sharp B, Harding GB. Culture of dialysis fluids on nutrient-rich media for short periods at elevated temperatures underestimate microbial contamination. Blood Purif 1996; 14: 136-145
36. Bergstrom J, Wehle B. No change in corrected β-microglobulin concentration after cuprophane haemodialysis. Lancet 1987; i: 628-629
37. Capelli G, Tetta C, Cornia F, Di Felice A, Facchini F, Neri R, Lucchi L, Lusvarghi E. Removal of limulus reactivity and cytokine-inducing capacity from bicarbonate dialysis fluids by ultrafiltration. Nephrol Dial Transplant 1993; 8: 1133-1139
38. Maeda K, Shinzato T. Push/pull hemodiafiltration: technical aspects and clinical effectiveness. Nephron 1995; 71: 1-9
39. Sterby J. A decade of experience with on-line hemofiltration/hemodiafiltration. Contrib Nephrol 1994; 108: 1-11
40. Gordon SM, Oettinger CW, Bland LA, Oliver JC, Arduino MJ, Aguero SM, McAllister SK, Favero MS, Jarvis WR. Pyrogenic reactions in patients receiving conventional, high-efficiency, or high-flux hemodialysis treatments with bicarbonate dialysate containing high concentrations of bacteria and endotoxin. J Am Soc Nephrol 1992; 2: 1436-1444
41. Krautzig S, Linnenweber S, Schindler R, Shaldon S, Koch KM, Lonnemann G. New indicators to evaluate bacteriological quality of the dialysis fluid and the associated inflammatory response in ESRD patients. Nephrol Dial Transplant 1996; 11 (Suppl.): 87-91
42. Takenaka T, Tsuchiya Y, Suzuki H. High-performance hemodiafiltration and blood pressure stability. Nephron 1997; 75: 30-35
43. Arese M, Cristol JP, Bosc JY, Bussolino F, Wratten ML, Tetta C, Strasly M, Canaud B. Removal of constitutive and inducible nitric oxide synthase-active compounds in a modified hemodiafiltration with on-line production of substitution fluid: the contribution of convection and diffusion. Int J Artif Organs 1996; 19: 704-711
44. van Kuijk WH, Wirtz JJ, Grave W, de Heer F, Menheere PP, van Hooff JP, Leunissen KM. Vascular reactivity during combined ultrafiltration haemodialysis: influence of dialysate sodium. Nephrol Dial Transplant 1996; 11: 323-328
45. Arese M, Cristol JP, Bosc JY, Bussolino F, Wratten ML, Tetta C, Strasly M, Canaud B. Removal of constitutive and inducible nitric oxide synthase-active compounds in a modified hemodiafiltration with on-line production of substitution fluid: the contribution of convection and diffusion. Int J Artif Organs 1996; 19: 704-711
46. von Albertini B, Miller JH, Gardner PW, Shinaberger JH. High-flux hemodiafiltration: under six hours/week treatment. Trans ASAIO 1984; 30: 227-230
47. Hakim RM, Breyer J, Ismail N, Schulman G. Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis 1994; 23: 661-669
48. Parker TF, Husni L, Huang W, Lew N, Lowrie EG, Dallas Nephrology Associates. Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis. Am J Kidney Dis 1994; 23: 670-680
49. Port F. Morbidity and mortality in dialysis patients. Kidney Int 1994; 46: 1728-1737
50. Birk HW, Kister A, Wizemann V, Schïtterle G. Protein adsorption by artificial membrane materials under filtration conditions. Artif Organs 1995; 19: 411-415
51. Langsdorf LJ. Effect of blood contact on the transport properties of hemodialysis membranes: a two-layer membrane model. Blood Purif 1994; 12: 292-307
52. Leypoldt JK. Fouling of ultrafiltration and hemodialysis membranes by plasma proteins. Blood Purif 1994; 12: 285-291
53. Floege J, Granolleras C, Deschodt G, et al. High-flux synthetic versus ccllulosic membranes for beta2-microglobulin during hemodialysis, hemodiafiltration and hemofiltration. Nephrol Dial Transplant 1989; 4: 653-657
54. Kerr PB, Argiles A, Flavier JL, Canaud B, Mion CM. Comparison of hemodialysis and hemodiafiltration: a long-term longitudinal study. Kidney Int 1992; 41: 1035-1040
55. Cheung AK. Quantification of dialysis. The importance of membrane and middle molecules. Blood Purif 1994; 12: 42-53
56. von Albertini B, Barlee V, Bosch JP. Double high-flux-hemodiafiltration: a mean to enhance efficiency and efficacy of dialysis. J Am Soc Nephrol 1996; 7: 1423 (Abstract)
57. Kubo S, Date H. Clinical usefulness of frequent short-time hemodiafiltration: trial for the effective removal of beta-2-microglobulin. Nephron 1996; 72: 93-97
58. Vlassara H. Serum advanced glycosylation end products: a new class of uremic toxins? Blood Purif 1994; 12: 54-59
59. Bucala R, Vlassara H. Advanced glycosylation end products in diabetic renal disease: clinical measurement, pathophysiological significance, and prospects for pharmacological inhibition. Blood Purif 1995; 13: 160-170
60. Ritz E, Deppisch R, Nawroth P. Toxicity of uraemia-does it come of AGE? Nephrol Dial Transplant 1994; 9: 1-2